Go to page
 

Bibliographic Metadata

Title
Effects of norepinephrine transporter gene variants on NET binding in ADHD and healthy controls investigated by PET
AuthorLanzenberger, Rupert ; Kasper, Siegfried ; Rujescu, Dan ; Hacker, Marcus ; Wadsak, Wolfgang ; Mitterhauser, Markus ; Traub-Weidinger, Tatjana ; Hienert, Marius ; Kautzky, Alexander ; Gryglewski, Gregor ; Vanicek, Thomas ; James, Gregory M. ; Rami-Mark, Christina ; Kranz, Georg S. ; Sigurdardottir, Helen L.
Published in
Human Brain Mapping, Hoboken, 2016, Vol. 37, Issue 3, page 884-895
PublishedHoboken : Wiley-Blackwell, 2016
LanguageEnglish
Document typeJournal Article
Keywords (EN)norepinephrine transporter / positron emission tomography / single nucleotide polymorphisms / neuroimaging genetics / attention deficit hyperactivity disorder / deficit-hyperactivity disorder / locus-coeruleus / human brain / in-vivo / major depression / association / methylphenidate / atomoxetine / promoter
Project-/ReportnumberP 22981-B09
ISSN1065-9471
URNurn:nbn:at:at-ubmuw:3-1458 Persistent Identifier (URN)
DOI10.1002/hbm.23071 
Restriction-Information
 The work is publicly available
Files
Effects of norepinephrine transporter gene variants on NET binding in ADHD and healthy controls investigated by PET [0.25 mb]
Links
Reference
Classification
Abstract (English)

Attention deficit hyperactivity disorder (ADHD) is a heterogeneous disorder with a strong genetic component. The norepinephrine transporter (NET) is a key target for ADHD treatment and the NET gene has been of high interest as a possible modulator of ADHD pathophysiology. Therefore, we conducted an imaging genetics study to examine possible effects of single nucleotide polymorphisms (SNPs) within the NET gene on NET nondisplaceable binding potential (BPND) in patients with ADHD and healthy controls (HCs). Twenty adult patients with ADHD and 20 HCs underwent (S,S)-[F-18]FMeNER-D-2 positron emission tomography (PET) and were genotyped on a MassARRAY MALDI-TOF platform using the Sequenom iPLEX assay. Linear mixed models analyses revealed a genotype-dependent difference in NET BPND between groups in the thalamus and cerebellum. In the thalamus, a functional promoter SNP (-3081 A/T) and a 5-untranslated region (5UTR) SNP (-182 T/C), showed higher binding in ADHD patients compared to HCs depending on the major allele. Furthermore, we detected an effect of genotype in HCs, with major allele carriers having lower binding. In contrast, for two 3UTR SNPs (*269 T/C, *417 A/T), ADHD subjects had lower binding in the cerebellum compared to HCs depending on the major allele. Additionally, symptoms of hyperactivity and impulsivity correlated with NET BPND in the cerebellum depending on genotype. Symptoms correlated positively with cerebellar NET BPND for the major allele, while symptoms correlated negatively to NET BPND in minor allele carriers. Our findings support the role of genetic influence of the NE system on NET binding to be pertubated in ADHD. Hum Brain Mapp 37:884-895, 2016. (c) 2015 The Authors Human Brain Mapping Published by Wiley Periodicals, Inc.

Stats
The PDF-Document has been downloaded 3 times.
License
CC-BY-License (4.0)Creative Commons Attribution 4.0 International License